Construction and application of curvularia lunata steroid C14 alpha-hydroxylase CYP5103B5 mutant
The invention provides curvularia lunata steroid C14 alpha-hydroxylase mutants Y10 (S129A/T130A/D131G/T132L/V133I/R134K/S135K) and D131G, and the coding nucleotide sequences of the curvularia lunata steroid C14 alpha-hydroxylase mutants Y10 (S129A/T130A/D131G/T132L/V133I/R134K/S135K) and D131G are s...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention provides curvularia lunata steroid C14 alpha-hydroxylase mutants Y10 (S129A/T130A/D131G/T132L/V133I/R134K/S135K) and D131G, and the coding nucleotide sequences of the curvularia lunata steroid C14 alpha-hydroxylase mutants Y10 (S129A/T130A/D131G/T132L/V133I/R134K/S135K) and D131G are shown as SEQ ID NO: 4 and SEQ ID NO: 6. Compared with C14 alpha-hydroxylase CYP5103B5, the mutant Y10 (S129A/T130A/D131G/T132L/V133I/R134K/S135K) and D131G have the advantages that the specificity of conversion of steroid substrate progesterone is obviously improved, and by-products are obviously reduced. The invention further provides an expression vector for heterologous overexpression of the CYP5103B5 mutant and a steroid transformation process of the expression vector, and valuable materials (genes and strains) and basic data support are provided for research and development of an efficient progesterone C14 alpha-hydroxylation production process.
本发明专利提供了新月弯孢霉甾体C14α-羟化酶突变体Y10(S129A/T130A/D131G/T132L/V133I/R134K/ |
---|